Shows your fuckers

[Anonymous No.654342]

>come here saying to invest In amrn, trying to help out my /biz/ bros
>stock was at .98 at that point
>people telling me to fuck off
>now at 1.35 and rising
>hedge funds starting to panic
>m-muh calls

I'm gonna enjoy riding this gravy train. See you at 10 bros

[Anonymous No.654363]

>>654342
>I bet on a biotech
>it went up
>we buffet now

[Anonymous No.654398]

>>654342
k

[Anonymous No.654426]

>>654342

I'd love to invest.
But I'm under the impression it's only worthwhile when you've got +6000 USD.

My girlfriend did something laughable recently and gave me a couple hundred to goof around with.
I was thinking, wtf is this shit. I can't do anything with this.

[Anonymous No.654461]

>>654342
Hedge funds OTC lol

[Anonymous No.655424]

>>654342
Nobody fucking cares Cap.

[Anonymous No.655425]

http://www.streetinsider.com/Hot+Upgrades/SunTrust+Upgrades+Amarin+Corporation+(AMRN)+to+Buy/10284127.html

[Anonymous No.655432]

>>654426

duhhhh either forex or leveraged ETFs

[Anonymous No.655471]

>>654342
>book value per share -.40

They'd have to pay me to take that piece of shit stock off their hands.

[Anonymous No.656324]

>tfw just made 4000 on a 12 cent rise off AMRN
>still going up after hours

[Anonymous No.656325]

>>654342
>drug approved in 2012
>still can't get significant revenue
>spending hundreds of millions on trials to get its previously denied "label expansion approved"
>moved up a bit because low float thinly traded stock got an upgrade
>similar movement to a pump and dump
>dat 2 year chart
Go away faggot
Just because something went up doesn't mean it was a smart investment.

[Anonymous No.656358]

>>656325

>Just because something went up doesn't mean it was a smart investment.


yes. yes, it does.

[Anonymous No.656388]

>>656358

just like when price goes above SMA and you get a .001% return :DDD

SO SMART

[Anonymous No.656390]

>>656325

>still can't get significant revenue

The script count Is at an all time high while generic lovaza and competitor scripts for high trigs are dropping. The script count alone will be enough in the next 6 months to fund the company

>spending hundreds of millions on trials

The reduce it fund is not that expensive and amarin has more than enough funds to cover it. Once reduce It is complete amarin will have wide label expansion for much broader horizons

>moved up a bit because pump and dump

Now I know you are just throwing words around with no common sense as to what you are spouting. Completely asinine

Amarin is severely undervalued as it is

[Anonymous No.656394]

AMRN will be a $5B-$10B market cap company just selling to Hypertrigs in US
Lovaza will disappear , $1B annual sale market just in US will be just Vascepa.
If we then consider non US countries just for Hyper trigs then $5B annual sales is achievable

If we then add High Trigs segment then we need to multiply $5B annual sales by ca 10 times.

So depending on which scenario we look at we may have annual revenue between $1B and $50B annual revenue, market cap between $5B and $250B, PPS between $30-$1,500

/biz/ has no clue what they are talking about sometimes

[Anonymous No.656438]

>>656358
No it doesn't.

A smart investment has a predicted return within a certain range.

Will anon pull out of amrn or will anon keep his shares because he expects infinit growth